Evidence map›Paper›PMID 26253816›Full record

ArticleNutrition research (New York, N.Y.)2015

Oat consumption reduced intestinal fat deposition and improved health span in Caenorhabditis elegans model.

Chenfei Gao, Zhanguo Gao, Frank L Greenway, Jeffrey H Burton, William D Johnson, Michael J Keenan, Frederick M Enright, Roy J Martin, YiFang Chu, Jolene Zheng

Open access · hybridAbstract read
In one paragraph

Article in Nutrition research (New York, N.Y.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. 4,4'-methylenediphenol reduces Aβ-induced toxicity in aFrontiers in aging neuroscience · 2024
    Article
  4. Article
  5. Multiple Antioxidative and Bioactive Molecules of Oats (Antioxidants (Basel, Switzerland) · 2021
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Pomegranate juice and extract extended lifespan and reduced intestinal fat deposition in Caenorhabditis elegans.International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Chenfei GaoSchool of Nutrition and Food Sciences, Louisiana State University, Agricultural Center, Baton Rouge, LA, 70803.
Zhanguo GaoAntioxidant and Gene Regulation Laboratory, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, 70808.
Frank L GreenwayOutpatient unit, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, 70808.
Jeffrey H BurtonDepartment of Biostatistics, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, 70808.
William D JohnsonDepartment of Biostatistics, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, 70808.
Michael J KeenanSchool of Nutrition and Food Sciences, Louisiana State University, Agricultural Center, Baton Rouge, LA, 70803.
Frederick M EnrightSchool of Animal Sciences, Louisiana State University, Agricultural Center, Baton Rouge, LA, 70803.
Roy J MartinUniversity of California, Davis, CA, 95616.
YiFang ChuQuaker Oats Center of Excellence, PepsiCo Global R&D Nutrition, Barrington, IL, 60010.
Jolene ZhengBioactive Screening Lab, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, 70808. Electronic address: Ccwork2015@outlook.com.
Pennington Biomedical Research Center · USLouisiana State University Agricultural Center · USPepsi (United States) · USUniversity of California, Davis · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI JUDD E SHELLITO · 2012 to 2026
$69.1M
NIGMS NIH HHS 1 U54 GM104940NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

In addition to their fermentable dietary fiber and the soluble β-glucan fiber, oats have unique avenanthramides that have anti-inflammatory and antioxidant properties that reduce coronary heart disease in human clinical trials. We hypothesized that oat consumption will increase insulin sensitivity, reduce body fat, and improve health span in Caenorhabditis elegans through a mechanism involving the daf-2 gene, which codes for the insulin/insulin-like growth factor-1-like receptor, and that hyperglycemia will attenuate these changes. Caenorhabditis elegans wild type (N2) and the null strains sir-2.1, daf-16, and daf-16/daf-2 were fed Escherichia coli (OP50) and oat flakes (0.5%, 1.0%, or 3%) with and without 2% glucose. Oat feeding decreased intestinal fat deposition in N2, daf-16, or daf-16/daf-2 strains (P < .05); and glucose did not affect intestinal fat deposition response. The N2, daf-16, or sir-2.1 mutant increased the pharyngeal pumping rate (P < .05), a surrogate marker of life span, following oat consumption. Oat consumption increased ckr-1, gcy-8, cpt-1, and cpt-2 mRNA expression in both the N2 and the sir-2.1 mutant, with significantly higher expression in sir-2.1 than in N2 (P < .01). Additional glucose further increased expression 1.5-fold of the 4 genes in N2 (P < .01), decreased the expression of all except cpt-1 in the daf-16 mutant, and reduced mRNA expression of the 4 genes in the daf-16/daf-2 mutant (P < .01). These data suggest that oat consumption reduced fat storage and increased ckr-1, gcy-8, cpt-1, or cpt-2 through the sir-2.1 genetic pathway. Oat consumption may be a beneficial dietary intervention for reducing fat accumulation, augmenting health span, and improving hyperglycemia-impaired lipid metabolism.

Indexed as

DietInsulin ResistanceAdipose TissueAnimalsAvenabeta-GlucansCaenorhabditis elegansCaenorhabditis elegans ProteinsDietary FiberEdible GrainFunctional FoodGlucoseHyperglycemiaInsulinInsulin-Like Growth Factor IIntestinal Mucosaavenanthramide-2Cbeta-GlucansCaenorhabditis elegans ProteinsDietary FiberGlucoseInsulinInsulin-Like Growth Factor Iortho-AminobenzoatesPlant PreparationsReceptor, InsulinRNA, MessengerSirtuinsC elegans modelHealth spanInsulin sensitivityLipid metabolismOats

Identifiers

PMID26253816
PMCPMC4561582
OpenAlexW1671256563

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.